CECCHI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.354
EU - Europa 4.447
AS - Asia 1.280
SA - Sud America 59
OC - Oceania 41
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.312
PL - Polonia 1.555
RU - Federazione Russa 1.207
HK - Hong Kong 437
IE - Irlanda 435
SE - Svezia 363
SG - Singapore 348
IT - Italia 347
CN - Cina 183
DE - Germania 152
UA - Ucraina 141
GB - Regno Unito 97
IN - India 97
JO - Giordania 80
FI - Finlandia 63
VN - Vietnam 55
BR - Brasile 51
AU - Australia 41
ID - Indonesia 38
CA - Canada 37
ES - Italia 25
NL - Olanda 16
FR - Francia 14
RO - Romania 12
TR - Turchia 10
CI - Costa d'Avorio 9
SC - Seychelles 7
CH - Svizzera 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
IR - Iran 5
JP - Giappone 5
KR - Corea 5
PH - Filippine 3
TN - Tunisia 3
AR - Argentina 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
IQ - Iraq 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
NO - Norvegia 2
PK - Pakistan 2
PT - Portogallo 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AT - Austria 1
BD - Bangladesh 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
LK - Sri Lanka 1
MU - Mauritius 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 12.208
Salva come PNG Salva come JPEG
Città #
Warsaw 1.555
Santa Clara 1.474
Fairfield 836
Dublin 434
Ashburn 398
Woodbridge 361
Hong Kong 347
Seattle 338
Cambridge 335
Chandler 320
Houston 286
Wilmington 264
Jacksonville 243
Singapore 198
Ann Arbor 127
Princeton 103
Lawrence 99
Altamura 95
Beijing 90
Mumbai 83
Boston 79
Florence 67
Dong Ket 48
Boardman 42
Buffalo 41
Medford 40
San Diego 40
Melbourne 39
Moscow 39
Jakarta 37
Shanghai 25
Norwalk 21
Toronto 19
New York 18
Barcelona 17
Los Angeles 16
Ottawa 16
Milan 14
Munich 14
Phoenix 13
Rome 12
The Dalles 12
West Jordan 12
Abidjan 9
London 9
Andover 8
Frankfurt Am Main 8
Hillsboro 8
Auburn Hills 7
Falls Church 7
Izmir 7
Falkenstein 6
Yubileyny 6
Brussels 5
Bucharest 5
Catania 5
Guangzhou 5
Helsinki 5
Mykolayiv 5
Prato 5
Seoul 5
Siena 5
Verona 5
Wuhan 5
Bern 4
Bologna 4
Frankfurt am Main 4
Lappeenranta 4
Madrid 4
Nanjing 4
Salerno 4
St Petersburg 4
Timisoara 4
Zhengzhou 4
Belo Horizonte 3
Calenzano 3
Chiswick 3
Council Bluffs 3
Genoa 3
Kent 3
Kilburn 3
Lucca 3
Nagoya 3
Naples 3
Quezon City 3
Redwood City 3
Saint Petersburg 3
São Paulo 3
Utrecht 3
Washington 3
Aguascalientes 2
Alseno 2
Bengaluru 2
Campinas 2
Canosa di Puglia 2
Chennai 2
Craiova 2
Dearborn 2
Duncan 2
Fiano Romano 2
Totale 8.905
Salva come PNG Salva come JPEG
Nome #
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. 270
Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy. 263
Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy. 260
The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils 249
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy 215
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy 202
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 196
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations 191
Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care 185
Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy 184
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy 173
Myocardial bridging and sudden death in hypertrophic cardiomyopathy: Salome drops another veil 172
Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a 13NH3 gated PET study 170
Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy 170
Echocardiography in patients with hypertrophic cardiomyopathy: Usefulness of old and new techniques in the diagnosis and pathophysiological assessment 165
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy 160
Prevalence and clinical significance of acquired left coronary artery fistulas after surgical myectomy in patients with hypertrophic cardiomyopathy 158
Malattia di Anderson-Fabry 156
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 152
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. 145
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol 145
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 145
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 145
Beta-Blockers for Prevention of Exercise-induced Left Ventricular Outflow Obstruction in Patients with Hypertrophic Cardiomyopathy 144
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 144
International external validation study of the 2014 European society of cardiology guidelines on sudden cardiac death prevention in hypertrophic cardiomyopathy (EVIDENCE-HCM) 143
Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives 143
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy insights from the sarcomeric human cardiomyopathy registry (SHaRe) 139
HYPERTROPHIC CARDIOMYOPATHY 138
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy. 137
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 136
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. 133
ARRHYTHMIAS ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY 131
Molecular Modeling of Disease Causing Mutations in Domain C1 of cMyBP-C 129
European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology 127
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. 123
Echocardiographic features of right ventricular infarction. 122
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy 122
Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy 120
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 117
Right ventricular infarction: clinical, hemodynamic, mono- and two-dimensional echocardiographic features. 116
CLINICAL PROFILE OF STROKE IN 900 PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY 115
Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy 115
Cardiovascular screening in low-income settings using a novel 4-lead smartphone-based electrocardiograph (D-Heart®) 114
Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. 113
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 113
THE ITALIAN REGISTRY FOR HYPERTROPHIC CARDIOMYOPATHY: A NATIONWIDE SURVEY 113
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: Impact of age, atrial remodelling, and disease progression 113
Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis. 112
Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy 110
IMPACT OF ATRIAL FIBRILLATION ON THE CLINICAL COURSE OF HYPERTROPHIC CARDIOMYOPATHY 109
RELEVANCE OF CORONARY MICROVASCULAR FLOW IMPAIRMENT TO LONG TERM REMODELING AND SYSTOLIC DYSFUNCTION IN HYPERTROPHIC CARDIOMYOPATHY 108
Pattern and degree of left ventricular remodeling following a tailored surgical approach for hypertrophic obstructive cardiomyopathy 108
Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy 108
MAXIMUM LEFT VENTRICULAR THICKNESS AND RISK OF SUDDEN DEATH IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY 106
RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY ASSESSED BY SIGNAL AVERAGED P WAVE DURATION 106
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 103
Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in Tuscany 102
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy 102
EPIDEMIOLOGY OF HYPERTROPHIC CARDIOMYOPATHY-RELATED DEATH: REVISITED IN A LARGE NON- REFERRAL-BASED PATIENT POPULATION 101
'End-stage' hypertrophic cardiomyopathy: from mystery to model 101
The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy 100
HYPERTROPHIC CARDIOMYOPATHY IN TUSCANY: CLINICAL COURSE AND OUTCOME IN AN UNSELECTED REGIONAL POPULATION 99
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy 99
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy 99
THE NEED FOR EUROPEAN REGISTRIES IN INHERITED CARDIOMYOPATHIES 98
Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy) 95
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy 94
An expert consensus document on the management of cardiovascular manifestations of Fabry disease 94
TRANSIENT ASYMMETRIC VENTRICULAR SEPTAL HYPERTROPHY IN THE NEWBORN UNASSOCIATED WITH MATERNAL DIABETES 94
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 94
Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team 93
Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy 91
Midventricular Obstruction and Clinical Decision-Making in Obstructive Hypertrophic Cardiomyopathy 89
Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long-term results and clinical outcomes 89
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy 88
Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy 85
PROGNOSTIC VALUE OF NON-SUSTAINED VENTRICULAR TACHYCARDIA AND THE POTENTIAL ROLE OF AMIODARONE TREATMENT IN HYPERTROPHIC CARDIOMIYOPATHY: ASSESSMENT IN AN UNSELECTED NON-REFERRAL BASEDE PATIENT POPULATION 85
EFFECT OF VERAPAMIL ON ABSOLUTE MYOCARDIAL BLOOD FLOW IN HYPERTROPHIC CARDIOMYOPATHY 84
CARDIOMIOPATIA IPERTROFICA 83
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy 83
RISK FACTORS AND STRATIFICATION FOR SUDDEN CARDIAC DEATH IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY 82
CLINICAL UTILITY AND SAFETY OF EXERCISE TESTING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY 82
Cardiomiopatie, Miocarditi e Pericarditi 82
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. 81
Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy 81
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 80
CLINICAL COURSE OF HYPERTROPHIC CARDIOMYOPATHY IN A NON SELECTED POPULATION. EXPERIENCE OF THE ITALIAN MULTICENTER CARDIOMYOPATHY STUDY 80
Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanism and clinical consequences 77
Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy 77
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy 76
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy 75
Surgical myectomy versus percutaneous alcohol ablation for obstructive hypertrophic cardiomyopathy: will there ever be a randomized trial 73
Stage-specific therapy for hypertrophic cardiomyopathy 72
NEW CONCEPTS IN HYPERTROPHIC CARDIOMYOPATHIES 71
CHARACTERISTICS OF MYOCARDIAL HYPERTROPHY IN FRIEDREICH'S ATAXIA. CLINICO-INSTRUMENTAL STUDY IN 10 PATIENTS AND REVIEW OF THE LITERATURE 71
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis 70
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 69
DIASTOLIC TIME INTERVALS BEFORE AN AFTER NADOLOL IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY 68
LONG-TERM OUTCOME OF PATIENTS WITH HYPERTROPHIC CARIOMYOPATHY SUCCESSFULLY RESUSCITATED AFTER CARDIAC ARREST 64
Totale 12.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020782 0 0 0 0 0 0 0 0 296 191 240 55
2020/20211.775 156 180 96 215 86 180 80 156 139 281 66 140
2021/2022723 32 33 66 28 29 43 29 46 46 36 151 184
2022/20231.694 169 272 89 95 131 315 245 69 220 14 61 14
2023/2024590 23 72 118 36 38 78 18 109 15 32 20 31
2024/20254.011 165 481 267 680 1.294 561 63 305 195 0 0 0
Totale 12.300